The Board of the Eurasian Economic Union has published decisions on the electronic submission of drug applications. These include decisions 78 and 79 of the board.

On 3rd August 2017, the Committee of the Eurasian Economic Union (EAEU) released the standards for EAEU electronic submissions. What will be the impact on applicants that would like to register a new drug in the EAEU? Is it the same as the ICH eCTD, only with a new regional module, M1? What are the guidelines that need to be followed?

The Board of the Eurasian Economic Union has published decisions on the electronic submission of drug applications. These include decisions 78 and 79 of the board.

Decision 78 gives details and clarifications on the content & structure of the submissions. For existing applicants, this will involve changes in regulatory requirements. Due to the change in the modules/sections structure, existing applications will have to be re-structured to adapt to the new structure and to comply with the current requirements. In general, the whole application procedure will change. From 31st December 2020, applicants will no longer be able to submit new applications as a national procedure; it will be replaced by either a Decentralized Procedure (DCP) / Mutual Recognition Procedure (MRP)  

Decision 79 of the board details the electronic submissions' technical compliance. Additional XML files need to be provided alongside with the PDF documents for a drug application. The XML for the application form is known as “R.017,” which contains information on the applicant company, the product, and the substance. A second XML, “R.022,” contains information on the documents submitted, together with specific identifiers for each document type.

Document quality is essential, and all scanned PDFs must be OCR processed to be searchable. No corrupt PDF files should be submitted. Password protection is also not advised to allow the reviewers to open the documents. There is a maximum file size restriction of 100MB for the documents.

Timelines for submitting in the new electronic format to the EAEU were published as follows:
New marketing authorizations in the EAEU must comply with the new electronic submission format from the 31st of December 2020 onwards. Follow-up submissions must be submitted in electronic format from 31st December 2025.

What does this mean for the applicant? What are the to-dos?

For all your existing applications, already approved in one of the EAEU member states, you should start getting prepared for the transition to the electronic format by:

  • updating the content and structure of your application to be compliant with decision 78
  • making documents electronic by scanning / OCR processing or creating new ones
  • additionally, it is advised that you submit a baseline submission of your existing dossier in electronic form

If you don’t have an existing, approved application already within one of the EAEU member states, you can start your application directly in the electronic format.

Five modules use XML files for metadata - so is it eCTD?

The submission format to the EAEU is not a regional implementation of the existing ICH eCTD standard, as seen in Europe, USA, Canada, or Australia implementations. It does have some similarities with eCTD submissions, especially when it comes to structuring and modules. Instead, the EAEU submission format has its own quite advanced but different XML format to submit additional data applications, documents, and lifecycles. This also clearly separates it from NeeS - the predecessor of eCTD. Sometimes you might hear it being referred to as the “eCTD for Eurasian Economic Union / EAEU,” - but don’t get confused by this, as technically, it is a new and independent standard of its own, not related to established eCTD standard.

Whether you’re based in the EAEU or anywhere else in the world, if you’re looking to submit electronic submissions in the EAEU, then EXTEDO has the technology and expertise you need- check out our EXTEDOpulse solutions or reach out to us today.

whiteWaveTop

Latest Blog Posts

500

Bertelsmann Investments Announces Another Major Investment in the Growing Pharma Tech Market

500

Interview: Meet EXTEDO’s Regulatory Intelligence (RI) Module!

500

Optimizing Life Sciences: EXTEDOpulse powered by CARA Unleashes the Power of Master Data Management in Regulatory Information Management (RIM)

500

Upcoming Changes in eCTD EU Module 1 Specification